Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT06838169
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older,
* Verbal communication,
* Place and time oriented,
* Without any psychiatric illness,
* Patients diagnosed with HF with NYHA class III-IV symptoms,
* Left ventricular ejection fraction ≥50% (LVEF-CF/HFpEF), between 40-49% (SEF-CF/HFmrEF), HF below 40% (DEF-CF/HFrEF),
* High levels of natriuretic peptides (BNP\>35 pg/mL and/or NTproBNP\>125 pg/mL),
* There is no deformity or diagnosis related to the musculoskeletal system that may prevent breathing exercise,
* Chronic diseases such as hypertension (Stage 1 and 2 HT) and diabetes mellitus are stable and the treatment for these diagnoses has not been changed in the last month,
* Who have not previously received respiratory exercise training and have not participated in a rehabilitation program,
* Patients who volunteer to participate in the study will be included in the study
Exclusion Criteria:
* Life signs are so abnormal as to preclude intervention,
* Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06838169
Study Brief:
Protocol Section:
NCT06838169